In gliomas, the high expression of GABPB1-AS1 can lead to the activation of cell cycle signal pathway and the progression of glioma cells (Li and Wang, 2021), while Qi et al. found that the high expression of GABPB1-AS1 is related to the improvement of overall survival of patients with hepatocellular carcinoma and can inhibit the antioxidant capacity of tumor cells (Qi et al., 2019). This evidence concerns the gene GABPB1 and hepatocellular carcinoma.